An old woman is required to receive 4 cycles of cancer chemotherapy. After her first cycle, she developed chemotherapy induced thrombocytopenia. Then in the next cycle, it would be appropriate to give this patient:

Oprelvekin acts like megakaryocyte colony stimulating factor and can be used to treat and prevent chemotherapy induced thrombocytopenia. Filgrastim (G-CSF) and sargramostim (GM-CSF) are used to prevent leucopenia. Iron Dextran (i/v or i/m) is used in Anaemia.